One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Older Patients and Cardiovascular Disease: At the Center of Care, on the Margins of Science
Effects of Intensive Blood Pressure Control in Patients With Frailty: A Post Hoc Analysis From ESPRIT
Frailty and Intensive Blood Pressure Control in ESPRIT: Risk, Benefit, and the Persistent Question of Generalizability
Frailty Scale Captures Multidimensional Vulnerability and Predicts Mortality in Heart Failure
Frailty in Cardiovascular Disease: Time for a Universal Definition!
Loss of Y Chromosome and Major Cardiovascular Events in a Prospective Study of Older Men
Wondering Y: How Might Loss of the Y Chromosome Promote Cardiovascular Disease in Aging Men?
CHIP, LOY, and Other Clonal Hematopoiesis Subtypes in Cardiovascular Disease
Vascular Cognitive Impairment and Dementia: Clinical Features, Neuropathology, and Biomarkers
Current and Emerging Therapeutic Approaches for Vascular Cognitive Impairment and Dementia
Myocarditis and Pericarditis in Focus: A Brief Report Comparing the 2025 ESC Guidelines and Latest ACC Position Papers
Giga-Trials Support Vaccination as Secondary Prevention for Cardiovascular Disease
A Time of Health Care Delivery Uncertainty: A Call for Member Engagement
Between 2 Heartbeats: The Space Between Prosperity and Precariousness
Is Switching From VKA to DOAC Universally Safe in Frail Elderly Patients With Atrial Fibrillation?
REPLY: Is Switching From VKA to DOAC Universally Safe in Frail Elderly Patients With Atrial Fibrillation?
